BEAM THERAPEUTICS INC shareholders Q3 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Candriam S.C.A. 79,665$3,795,0000.03%
Tower Research Capital LLC (TRC) 34,463$1,642,0000.03%
PROFUND ADVISORS LLC 7,949$379,0000.03%
FMR LLC 4,584,135$218,389,0000.02%
Walleye Capital LLC 23,400$1,115,0000.02%
NATIXIS 92,619$4,412,0000.02%
Cubist Systematic Strategies, LLC 77,102$3,673,0000.02%
Point72 Hong Kong Ltd 12,477$594,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 510,931$24,341,0000.02%
AllSquare Wealth Management LLC 560$27,0000.02%
Baillie Gifford 385,218$18,351,0000.02%
China Universal Asset Management Co., Ltd. 895$43,0000.02%
SCHRODER INVESTMENT MANAGEMENT GROUP 210,642$10,035,0000.02%
LMR Partners LLP 18,275$871,0000.02%
TWO SIGMA ADVISERS, LP 101,000$4,812,0000.01%
CWM, LLC 35,747$1,703,0000.01%
MetLife Investment Management, LLC 34,379$1,637,8160.01%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 21,505$1,024,0000.01%
Penserra Capital Management LLC 9,639$459,0000.01%
Connor, Clark & Lunn Investment Management Ltd. 42,687$2,034,0000.01%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q3 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.